MedTrace Logo

Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients

NCT02084407 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2014-09-26

No results posted yet for this study

Summary

The objective of the study is the modelisation of human cardiomyocyts from pluripotent stem cells in order to study the cardiac alterations induced by CTG expansions.

Conditions

Interventions

OTHER

Clinical examination, skin biopsy, blood and urine sampling

Sponsors & Collaborators

  • Institut de Myologie, France

    lead OTHER

Principal Investigators

  • Laurent Servais, MD PhD · Institute of Myology

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02084407 on ClinicalTrials.gov